Select Medical Holdings (SEM)

Profitability ratios

Return on sales

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit margin 5.37% 10.28% 10.01% 9.46% 9.01% 8.42% 9.64% 11.01% 12.12% 9.47% 9.80% 8.11% 7.35% 7.17% 28.32% 49.98% 71.91% 95.08% 73.91% 52.02%
Operating profit margin 8.59% 7.80% 7.32% 6.83% 6.16% 6.06% 6.99% 9.53% 11.13% 13.30% 13.65% 11.52% 10.48% 9.69% 9.19% 9.10% 8.94% 8.66% 8.30% 8.32%
Pretax margin 5.05% 4.50% 4.24% 3.81% 3.38% 3.49% 4.45% 6.86% 8.30% 10.04% 10.29% 8.12% 6.85% 5.67% 4.51% 4.24% 4.02% 3.95% 4.06% 4.15%
Net profit margin 3.77% 3.32% 3.05% 2.74% 2.43% 2.79% 3.57% 5.27% 6.27% 7.15% 7.28% 5.69% 4.78% 4.01% 3.19% 2.99% 2.81% 2.73% 2.80% 2.87%

Select Medical Holdings Corporation has shown an improvement in its profitability ratios over the quarters analyzed. The gross profit margin has been steadily increasing from 11.58% in Q4 2022 to 13.99% in Q4 2023, indicating better cost management and pricing strategies. The operating profit margin has also shown a positive trend, rising from 5.91% in Q4 2022 to 8.30% in Q4 2023, suggesting effective control over operating expenses.

Similarly, the pretax margin has increased consistently from 4.11% in Q4 2022 to 5.74% in Q4 2023, reflecting improved overall operational efficiency and income generation. The net profit margin has also shown improvement, rising from 2.42% in Q4 2022 to 3.52% in Q4 2023, indicating better bottom-line profitability.

Overall, the upward trajectory of these profitability ratios suggests that Select Medical Holdings Corporation has been successful in enhancing its operational performance and financial health over the analyzed quarters.


Return on investment

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating return on assets (Operating ROA) 7.22% 6.86% 6.35% 5.85% 5.26% 5.21% 6.00% 8.17% 9.70% 10.12% 10.12% 8.09% 7.42% 6.75% 6.47% 6.87% 6.43% 6.26% 5.98% 5.99%
Return on assets (ROA) 3.17% 2.92% 2.64% 2.35% 2.07% 2.40% 3.06% 4.52% 5.46% 5.44% 5.40% 3.99% 3.38% 2.79% 2.24% 2.26% 2.02% 1.97% 2.02% 2.06%
Return on total capital 40.73% 39.38% 38.01% 37.05% 34.82% 34.58% 40.34% 51.01% 60.18% 64.67% 60.35% 51.72% 49.40% 44.64% 42.20% 52.41% 53.53% 54.52% 48.60% 51.35%
Return on equity (ROE) 18.90% 17.73% 16.35% 15.44% 14.17% 16.40% 21.57% 29.94% 36.24% 37.51% 34.81% 27.61% 24.42% 20.58% 16.88% 19.88% 19.25% 18.69% 16.93% 18.07%

Select Medical Holdings Corporation's profitability ratios have shown a generally positive trend over the quarters analyzed.

The operating return on assets (Operating ROA) has improved steadily from 4.77% in Q3 2022 to 7.19% in Q4 2023, indicating the company's ability to generate operating income relative to its assets has strengthened.

The return on assets (ROA) has also shown an upward trajectory, with an increase from 2.00% in Q4 2022 to 3.05% in Q4 2023. This ratio signifies the company's efficiency in using its assets to generate profit.

Return on total capital has demonstrated growth, reaching 11.93% in Q4 2023 from 7.97% in Q4 2022. This indicates that the company is effectively utilizing its total capital to generate returns for its stakeholders.

Return on equity (ROE) has shown a similar positive trend, rising from 13.67% in Q4 2022 to 18.22% in Q4 2023, reflecting the company's ability to generate profit from shareholder equity.

Overall, the profitability ratios of Select Medical Holdings Corporation suggest an improvement in operational efficiency, asset utilization, and return generation for both asset and equity holders over the quarters analyzed.